Is it any surprise that Canada's life sciences and pharmaceutical industry receives one out of every four dollars of venture capital investment? After all, an aging Canadian population has significantly increased demand for health-related products and treatment, and the sector is working hard to keep up. With the global pharmaceutical market predicted to double to $1.8 trillion by 2020, there is a lot at stake for Canadian players in this sector.
Yet there are unique challenges facing our life sciences and pharmaceutical industry. Canadian patent rules are inconsistent with those in the United States, leaving many companies with less time to fully realize the value from their intellectual property. Canadian companies are also subject to complex regulatory regimes, and this can hamper innovation as the industry shifts focus from health treatment to preventative care.
As a Canadian life sciences or pharmaceutical company, you face many issues that affect both short-term and long-term strategies for your business growth. These can include:
How we can help
PwC offers a range of services that can help you tackle the complex issues impacting the Canadian life sciences and pharmaceutical sector. We offer help with corporate governance issues, regulatory compliance, information technology effectiveness, human resource solutions and benchmarking. We also have a wide network of contacts in the venture capital and private equity sectors and can quickly put you in touch with the people you need to know. Contact us today to see how we can help you.